Description
A third-generation, broad-spectrum cephalosporin antibiotic that disrupts the synthesis of the peptidoglycan layer of bacterial cell walls; increases EAAT-2 pump expression in the CNS and reduces glutamatergic toxicity in both in vitro and in vivo models
Formal name: (6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, disodium salt, hemiheptahydrate
Synonyms: Ceftriaxone disodium hemiheptahydrate|Ro 13-9904|Rosihlitazone
Molecular weight: 661.6
CAS: 104376-79-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics|Cephalosporins||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Neuroscience